A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia

Not Applicable

Not yet recruiting

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2000003235
• Lead Sponsor: Wuhan Hospital Of Traditional Chinese and Western Medicine (Wuhan 1st Hospital)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the convalescence of COVID-19 diagnostic criteria;
2. Short breath, hyperhidrosis, dry cough, chest distress, palpitation and other clinical discomfort symptoms of lung and heart function decline, in which 3 symptoms appear at the same time, or the visual analogue score of single symptom (VAS) >=4 points;
3. Patients who were discharged for more than 2 weeks were cured;
4. Aged 18-70 years old;
5. Sign informed consent.

Exclusion Criteria

1. Because of other reasons, such as shortness of breath, hyperhidrosis, dry cough, chest distress, palpitation, etc;
2. Patients with difficulty in taking drugs orally due to basic diseases;
3. There are serious basic diseases that affect survival, including uncontrolled clinically significant heart, lung, kidney, digestion, blood disease, neuropsychiatric disease, immune disease, metabolic disease, malignant tumor, severe malnutrition, etc;
4. Allergic constitution, allergic to drugs involved in the treatment plan;
5. Pregnant or lactating women;
6. Those who can't cooperate in mental state, suffer from mental disease, have no self-control and can't express clearly;
7. Those who are participating in other clinical trials;
8. According to the judgment of the researchers, there will be patients with complicated enrollment or poor compliance that affect the efficacy and safety evaluation.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
VAS;